Research report
Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization

https://doi.org/10.1016/S0166-4328(97)83329-3Get rights and content

Abstract

In an earlier study we showed that co-administration of the NMDA-receptor antagonist MK-801 during conditioning sessions blocks morphine-induced conditioned place preference (CPP). From this result, the question arose of whether this blockade is due to state-dependency effects induced by MK-801. Therefore, in a first experiment, animals were tested in the drugged state under which they had been conditioned. These animals did not show a CPP, thus it can be concluded that MK-801 does not make statedependent the morphine conditioning. In the same experiment those animals receiving only morphine during conditioning sessions showed a significant CPP when tested in an undrugged state but failed to show CPP when tested after injection of MK-801 (i.e., in the drugged state). These results indicate that MK-801 not only blocks the development of morphine-induced CPP but is also able to block the expression of a conditioned response that has been acquired before. In the same experiment repeated injection of neither morphine nor MK-801 produced sensitized locomotor activity. However, a strong sensitization was observed following repeated injection of morphine plus MK-801. There was also cross-sensitization between morphine plus MK-801 and MK-801 alone but not with morphine alone, and also between morphine and MK-801, but not vice versa. In a second experiment the effects of the AMPA-receptor antagonist GYKI 52466 were examined. It was found that GYKI 52466 did not produce CPP or behavioural sensitization. Finally, in a third experiment, CPP was induced by morphine and amphetamine (animals tested in the drug-free state), and behavioural sensitization was induced by amphetamine. When animals were tested after an injection of GYKI 52466, neither the morphine- nor the amphetamine-conditioned animals showed a CPP. Likewise, challenge of sensitized animals with amphetamine plus GYKI 52466 failed to produce a sensitized response. It can be concluded, that GYKI 52466, like MK-801, can block the expression of a conditioned response, and can also block the expression of sensitized behaviour.

References (49)

  • R. Karler et al.

    Blockade of ‘reverse tolerance’ to cocaine and amphetamine by MK-801

    Life Sci.

    (1989)
  • R. Karler et al.

    DNQX blockade of amphetamine behavioral sensitization

    Brain Res.

    (1991)
  • U. Keseberg et al.

    Low-dose challenge by the NMDA receptor antagonist dizocilpine exacerbates the spatial learning deficit in ntorhinal cortex-lesioned rats

    Behav. Brain Res.

    (1995)
  • G.F. Koob

    Drugs of abuse: anatomy, pharmacology and function of reward pathways

    Trends Pharmacol. Sci.

    (1992)
  • R.T. Layer et al.

    The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats

    Pharmacol. Biochem. Behav.

    (1993)
  • D.T. Manallack et al.

    Subchronic administration of MK801 in the rat decreases cortical binding of [3H]D-AP5

    Neuroscience

    (1989)
  • P. Marek et al.

    Delayed application of MK-801 attenuates development of morphine tolerance in rats

    Brain Res.

    (1991)
  • C. Spyraki et al.

    Dopaminergic substrates of amphetamine-induced place preference conditioning

    Brain Res.

    (1982)
  • C. Spyraki et al.

    Intravenous cocaine-induced place preference: attenuation by haloperidol

    Behav. Brain Res.

    (1987)
  • K.J. Sufka

    Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain

    Pain

    (1994)
  • T.M. Tzschentke et al.

    N-Methyl-d-aspartic acidreceptor antagonists block morphine-induced conditioned place preference in rats

    Neurosci. Lett.

    (1995)
  • M.E. Wolf et al.

    Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization

    Brain Res.

    (1993)
  • M.E. Wolf et al.

    Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine

    Brain Res.

    (1991)
  • M. Babbini et al.

    Time-dose relationships for locomotor activity effects of morphine after acute or repeated treatment

    Br. J. Pharmacol.

    (1972)
  • Cited by (0)

    View full text